These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9509066)

  • 1. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort.
    Vanderpump MP; French JM; Appleton D; Tunbridge WM; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):39-44. PubMed ID: 9509066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.
    Vanderpump MP; Tunbridge WM; French JM; Appleton D; Bates D; Clark F; Grimley Evans J; Hasan DM; Rodgers H; Tunbridge F
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):55-68. PubMed ID: 7641412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS).
    Soto-Pedre E; Newey PJ; Bevan JS; Greig N; Leese GP
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):60-67. PubMed ID: 27434534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men.
    Romeo JH; Dombrowski R; Kwak YS; Fuehrer S; Aron DC
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):571-5. PubMed ID: 8977754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of Serum Gonadotropin Levels in Hyperprolactinaemia.
    Abbara A; Clarke SA; Nesbitt A; Ali S; Comninos AN; Hatfield E; Martin NM; Sam AH; Meeran K; Dhillo WS
    Neuroendocrinology; 2018; 107(2):105-113. PubMed ID: 29660734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.
    Colao A; Di Sarno A; Guerra E; Pivonello R; Cappabianca P; Caranci F; Elefante A; Cavallo LM; Briganti F; Cirillo S; Lombardi G
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):426-33. PubMed ID: 17573902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis.
    Notsu K; Ito Y; Furuya H; Ohguni S; Kato Y
    Endocr J; 1997 Feb; 44(1):89-94. PubMed ID: 9152619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
    Bushe C; Shaw M
    J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
    Whyte MB; Pramodh S; Srikugan L; Gilbert JA; Miell JP; Sherwood RA; McGregor AM; Aylwin SJ
    Pituitary; 2015 Jun; 18(3):319-25. PubMed ID: 24879500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
    Sayki Arslan M; Sahin M; Topaloglu O; Tutal E; Karakose M; Gungunes A; Cakal E; Ozbek M; Delibasi T
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):882-6. PubMed ID: 23551036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hyperprolactinaemia in female premenopausal blood donors.
    Alpañés M; Sanchón R; Martínez-García MÁ; Martínez-Bermejo E; Escobar-Morreale HF
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):545-9. PubMed ID: 23445257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
    Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia.
    Karunakaran S; Page RC; Wass JA
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):295-300. PubMed ID: 11298080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary macroadenomas associated with hyperprolactinaemia: immunocytochemical and in-situ hybridization studies.
    McNicol AM; Walker E; Farquharson MA; Teasdale GM
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):239-44. PubMed ID: 1742881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral content in normally menstruating women with hyperprolactinaemia.
    Nyström E; Leman J; Lundberg PA; Lindquist O; Hansson T; Bengtsson C; Rybo G; Lindstedt G
    Horm Res; 1988; 29(5-6):214-7. PubMed ID: 3220459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia.
    Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.